Feb 11 (Reuters) - Mesoblast Ltd MSB.AX :
* PHASE 3 TRIAL OF ALLOGENEIC MESENCHYMAL PRECURSOR CELL THERAPY SHOWS SINGLE INJECTION RESULTS IN AT LEAST 2-YRS OF PAIN REDUCTION
Feb 11 (Reuters) - Mesoblast Ltd MSB.AX :
* PHASE 3 TRIAL OF ALLOGENEIC MESENCHYMAL PRECURSOR CELL THERAPY SHOWS SINGLE INJECTION RESULTS IN AT LEAST 2-YRS OF PAIN REDUCTION